Korean Biopharmaceutical Company, CorestemChemon, Selects Winston-Salem’s Wake Forest Institute for Regenerative Medicine for US Base of OperationsÂ
Company to locate in the RegenMed Engine, Receives BioNest Grant to Support US Base of Operations CorestemChemon, a biopharmaceutical company headquartered in South Korea, has selected Winston-Salem as the location for its U.S. base of operations. The company will be located within the Regenerative Medicine…
